NEW YORK, March 29 - Early-stage biotech companies, including genomic tool and technology firms, are enjoying the best venture-capital market in a decade, according to results of a recent market study.

Subscribers: click headline for more.

Subscribers: click headline for more.

DNA microarrays are standing on the doorstep of clinical research: Every other week, it seems a scientific study in a high-profile journal like Nature or The Lancet reports the discovery of a new set of biomarkers, based on gene expression data from microarray experiments that may help, for example, predict the clinical outcome of cancer. Subscribers: click headline for more.

Subscribers: click headline for more.

Subscribers: click headline for more.

This article is available to subscribers of BioArray News.

NEW YORK, March 29 - Microarrays can be used to predict patient responses to treatment for pediatric acute lymphoblastic leukemia, a group of researchers at Memphis' St.

Inside the mirrored glass walls of its expansive La Jolla, Calif., headquarters, Illumina is trying to make the microarray revolution happen all over again.Subscribers: click headline for more.

Subscribers: click headline for more.

NEW YORK, March 27 - CuraGen on Thursday said it has put in place a stockholder rights plan it hopes will protect its "lo

NEW YORK, March 28 - Researchers will be allowed only limited public access to Syngenta's rice-sequence data when a major paper on the genome is published in Science next week, the journal said on Thursday.

SAN FRANCISCO, March 28 - While some researchers build a better mouse assembly, others have their eyes on c

NEW YORK, March 28 - Cytyc will extend the expiration date of its offer to acquire Digene after the US Federal Trade Commission asked the company for more information about the proposed deal.

NEW YORK, March 27-Protein Design Labs hired Brett Schmidli as senior vice president of technical operations, the company said yesterday.

NEW YORK, March 27-Biotech investment jumped about 18 percent last year in Connecticut, according to an analysis released yesterday evening by an industry group.

NEW YORK

SANTA CRUZ, Calif., March 27 - Bioinformatics companies have had their share of ups and downs over the last  several months.

NEW YORK, March 27 - Isis

This article is available to subscribers of BioInform.

NEW YORK, March 26 - Affymetrix and Monsanto on Tuesday said they plan to co-develop a single microarray that represents the Arabidopsis genome.

NEW YORK, March 26 - CombiMatrix has withdrawn its planned initial public offering on Monday, but a previously announced move that would give the firm its own Nasdaq listing is still on.

NEW YORK, March 26 - InforMax said on Tuesday it has licensed its GenoMax informatics platform to Johns Hopkins University School of Medicine Microarray Core Facility.  

NEW YORK, March 26 - The Mayo Clinic is pursuing collaborations with genomic tool and technology companies to help it fulfill an ambitious plan of creating a comprehensive gene-based patient-data library, a Mayo spokesman told GenomeWeb on Tues

This story has been updated from a previous version to include comment from the Biotechnology Industry Organization.